JAGLX vs. BBH
Compare and contrast key facts about Janus Henderson Global Life Sciences Fund Class T (JAGLX) and VanEck Vectors Biotech ETF (BBH).
JAGLX is an actively managed fund by Janus Henderson. It was launched on Dec 31, 1998. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011.
Performance
JAGLX vs. BBH - Performance Comparison
Loading graphics...
JAGLX vs. BBH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JAGLX Janus Henderson Global Life Sciences Fund Class T | -3.75% | 24.72% | 8.50% | 7.41% | -2.79% | 6.66% | 25.52% | 29.12% | 4.05% | 22.13% |
BBH VanEck Vectors Biotech ETF | 0.04% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
Returns By Period
In the year-to-date period, JAGLX achieves a -3.75% return, which is significantly lower than BBH's 0.04% return. Over the past 10 years, JAGLX has outperformed BBH with an annualized return of 11.55%, while BBH has yielded a comparatively lower 6.42% annualized return.
JAGLX
- 1D
- 3.08%
- 1M
- -5.56%
- YTD
- -3.75%
- 6M
- 11.82%
- 1Y
- 21.58%
- 3Y*
- 12.33%
- 5Y*
- 8.24%
- 10Y*
- 11.55%
BBH
- 1D
- 0.70%
- 1M
- -3.58%
- YTD
- 0.04%
- 6M
- 10.55%
- 1Y
- 23.57%
- 3Y*
- 5.92%
- 5Y*
- 1.84%
- 10Y*
- 6.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
JAGLX vs. BBH - Expense Ratio Comparison
JAGLX has a 0.92% expense ratio, which is higher than BBH's 0.35% expense ratio.
Return for Risk
JAGLX vs. BBH — Risk / Return Rank
JAGLX
BBH
JAGLX vs. BBH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janus Henderson Global Life Sciences Fund Class T (JAGLX) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| JAGLX | BBH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.06 | 1.05 | +0.02 |
Sortino ratioReturn per unit of downside risk | 1.53 | 1.53 | 0.00 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.20 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | 1.78 | 2.00 | -0.22 |
Martin ratioReturn relative to average drawdown | 4.92 | 5.56 | -0.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| JAGLX | BBH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.06 | 1.05 | +0.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.53 | 0.09 | +0.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.66 | 0.29 | +0.38 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.58 | 0.27 | +0.31 |
Correlation
The correlation between JAGLX and BBH is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
JAGLX vs. BBH - Dividend Comparison
JAGLX's dividend yield for the trailing twelve months is around 4.70%, more than BBH's 0.51% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JAGLX Janus Henderson Global Life Sciences Fund Class T | 4.70% | 4.53% | 10.98% | 4.22% | 0.14% | 9.78% | 7.75% | 6.17% | 13.38% | 0.89% | 1.13% | 9.09% |
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
Drawdowns
JAGLX vs. BBH - Drawdown Comparison
The maximum JAGLX drawdown since its inception was -58.96%, smaller than the maximum BBH drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for JAGLX and BBH.
Loading graphics...
Drawdown Indicators
| JAGLX | BBH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.96% | -72.70% | +13.74% |
Max Drawdown (1Y)Largest decline over 1 year | -9.71% | -10.47% | +0.76% |
Max Drawdown (5Y)Largest decline over 5 years | -22.25% | -39.86% | +17.61% |
Max Drawdown (10Y)Largest decline over 10 years | -27.38% | -39.86% | +12.48% |
Current DrawdownCurrent decline from peak | -6.64% | -12.15% | +5.51% |
Average DrawdownAverage peak-to-trough decline | -17.51% | -26.05% | +8.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.63% | 3.76% | -0.13% |
Volatility
JAGLX vs. BBH - Volatility Comparison
The current volatility for Janus Henderson Global Life Sciences Fund Class T (JAGLX) is 5.99%, while VanEck Vectors Biotech ETF (BBH) has a volatility of 7.01%. This indicates that JAGLX experiences smaller price fluctuations and is considered to be less risky than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| JAGLX | BBH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.99% | 7.01% | -1.02% |
Volatility (6M)Calculated over the trailing 6-month period | 10.63% | 13.69% | -3.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.86% | 22.72% | -4.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.76% | 21.47% | -5.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.45% | 22.27% | -4.82% |